p97
p97 is a AAA-type ATPase that involved in mitosis-related events, such as golgi stacks fragmentation, tER formation, spindle pole body function and homotypic membrane fusion etc.
Products for p97
- Cat.No. Product Name Information
-
GC16351
CB-5083
p97 inhibitor
-
GC20117
CB-5339
CB-5339 is a second generation, potent and selective, orally bioavailable, ATP-competitive, small molecule inhibitor of valosin containing protein (VCP)/p97 [1,2].
-
GC10824
DBeQ
N,N'Dibenzylquinazoline2,4diamine, JRF 12
P97 ATPase inhibitor -
GC14059
ML 240
ATP-competitive inhibitor of p97 ATPase
-
GC11749
ML241
p97 ATPase inhibitor
-
GC13656
ML241 hydrochloride
p97 ATPase inhibitor
-
GC10048
MNS
3,4Methylenedioxyβnitrostyrene, NSC 10120, NSC 105303, NSC 170724, Syk Inhibitor III
Inhibitor of Src/Syk tyrosine kinases -
GC60257
MSC1094308
MSC1094308 is a non-competitive and reversible VPS4B/p97 (VCP) (I/II type AAA ATPase) allosteric inhibitor, with IC50 values of 0.71 μM and 7.2 μM for VPS4B and p97, respectively. MSC1094308 inhibits the D2 ATPase activity by binding to a drugable hotspot of p97. MSC1094308 can be used in study of cancer.
-
GC32874
NMS-859
NMS-859 is a potent, covalent VCP (p97) inhibitor, with IC50s of 0.37 and 0.36 μM for wild-type VCP in the presence of 60 μM and 1 mM ATP in cells, respectively.
-
GC17250
NMS-873
VCP Inhibitor III
VCP/p97 inhibitor,selective and allosteric -
GC64694
UPCDC-30245
UPCDC-30245 is an allosteric p97 inhibitor with an IC50 of approximately 27 nM. UPCDC-30245 inhibits the p97 mutant N660K similar to wild type (WT; IC50=300 nM) and shows 3-fold resistance for p97 mutant T688A. UPCDC-30245 can be used in the research of cancer.
-
GC71429
VCP Activator 1
VCP Activator 1 is a VCP activator that dose-dependently stimulates VCP ATPase activity.